BR100 Decreased By (-0.91%)
BR30 Decreased By (-1.47%)
KSE100 Decreased By (-0.78%)
KSE30 Decreased By (-0.75%)
AGHA 6.67 Decreased By ▼ -0.01 (-0.15%)
BECO 4.35 Decreased By ▼ -0.02 (-0.46%)
BML 56.17 Decreased By ▼ -1.15 (-2.01%)
BOP 30.12 Decreased By ▼ -0.23 (-0.76%)
CNERGY 12.98 Decreased By ▼ -0.14 (-1.07%)
CSIL 5.31 Decreased By ▼ -0.10 (-1.85%)
FCCL 51.65 Decreased By ▼ -1.14 (-2.16%)
FFL 14.49 Decreased By ▼ -0.23 (-1.56%)
FNEL 1.21 Increased By ▲ 0.09 (8.04%)
KEL 6.06 Decreased By ▼ -0.03 (-0.49%)
KOSM 5.84 Increased By ▲ 0.11 (1.92%)
LOTCHEM 26.17 Decreased By ▼ -0.29 (-1.1%)
MLCF 91.23 Decreased By ▼ -1.93 (-2.07%)
NBP 164.19 Decreased By ▼ -0.47 (-0.29%)
NCPL 53.18 Decreased By ▼ -2.48 (-4.46%)
NPL 59.12 Decreased By ▼ -2.04 (-3.34%)
OGDC 313.39 Decreased By ▼ -3.34 (-1.05%)
PACE 9.77 Decreased By ▼ -0.10 (-1.01%)
PAEL 35.24 Decreased By ▼ -0.39 (-1.09%)
PIBTL 14.71 Increased By ▲ 0.03 (0.2%)
PPL 221.36 Decreased By ▼ -5.55 (-2.45%)
PRL 91.22 Decreased By ▼ -1.80 (-1.94%)
PTC 59.19 Decreased By ▼ -1.07 (-1.78%)
SSGC 23.30 Decreased By ▼ -0.51 (-2.14%)
TBL 8.75 No Change ▼ 0.00 (0%)
TELE 7.61 Decreased By ▼ -0.19 (-2.44%)
TPL 22.03 Decreased By ▼ -0.32 (-1.43%)
TPLP 12.56 Decreased By ▼ -0.41 (-3.16%)
TREET 21.73 Decreased By ▼ -0.43 (-1.94%)
TRG 55.79 Decreased By ▼ -0.77 (-1.36%)
By

ISLAMABAD: Parliamentary Secretary, National Health Services Regulations and Coordination Dr Nausheen Hamid Sunday said that the coronavirus vaccine development was in its final stages as China has assured to provide 500,000 doses of Covid-19 vaccine to Pakistan by January 31.

The frontline staff will be the first ones to receive the COVID-19 vaccine and more than 3 lakh frontline workers have been identified to carry out vaccination process in first phase which is set to begin from end of February, she said while talking to a private news channel.

She said that Pakistan had approved Sinopharm vaccine for emergency use in Pakistan and expressed hope for its early availability from China, adding, the vaccine is being developed by CanSinoBio and the Beijing Institute of Biotechnology China.

Nausheen Hamid said the Chinese vaccine is also successfully undergoing phase 3 trials, adding, it was an “honor” for Pakistan to be among the few countries participating in “the biggest and relatively difficult” phase-3 study of a vaccine”.

She explained the first phase of the Covid-19 vaccination was dedicated for the frontline healthcare workers who were part of this challenge. In the second phase senior citizens aged 65 and over while in the third one the general population would be vaccinated.

She said government was under close contact with three international firms manufacturing the Covid-19 vaccine.

Comments

Comments are closed for this article.